D-0426-2024 Class II Terminated
FDA drug recall D-0426-2024 was initiated by Amneal Pharmaceuticals Of New York, LLC on Dec 26, 2023 and is designated Class II. Reason for recall: Failed dissolution specifications The recall status is terminated (terminated Aug 16, 2024). Affected quantity: 21,452/100 count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 3, 2024
- Initiation Date
- Dec 26, 2023
- Termination Date
- Aug 16, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 21,452/100 count bottles
Product description
Divalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Ahmedabad, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 65162-755-10. NDC# 65162-755-10
Reason for recall
Failed dissolution specifications
Distribution pattern
Product was distributed nationwide.
Code information
Lot # AR210704, exp. date 04/2024 AR210706, exp. date 04/2024 AR210707, exp. date 04/2024 AR210708, exp. date 04/2024 AR210709, exp. date 04/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0426-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026